nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Factual Inaccuracy Noted in the Conclusions Specifically Regarding the Novelty of the Author’s Work in the Middle East
|
Farid, Samar |
|
|
28 |
6 |
p. 975 |
artikel |
2 |
A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland
|
Barrett, Rosealeen |
|
|
28 |
6 |
p. 844-851 |
artikel |
3 |
A Person-Centered eHealth Intervention for Patients With Common Mental Disorders: Cost-Effectiveness Analysis Within a Randomized Controlled Trial
|
Kebede, Tayue T. |
|
|
28 |
6 |
p. 875-883 |
artikel |
4 |
Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study
|
Sullivan, Trudy A. |
|
|
28 |
6 |
p. 936-944 |
artikel |
5 |
Costs and Health Outcomes in Economic Evaluations of Person-Centered Care: A Systematic Review
|
Elhassan, Hadeel |
|
|
28 |
6 |
p. 852-865 |
artikel |
6 |
Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods
|
Vickers, Andrew |
|
|
28 |
6 |
p. 894-897 |
artikel |
7 |
Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices
|
Hariz, Amira J. |
|
|
28 |
6 |
p. 945-958 |
artikel |
8 |
Editorial Board
|
|
|
|
28 |
6 |
p. vi |
artikel |
9 |
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report
|
Henderson, Raymond H. |
|
|
28 |
6 |
p. 813-820 |
artikel |
10 |
Performance of the EQ-5D-5L With Skin Irritation and Self-Confidence Bolt-On Items in Patients With Urticaria
|
Feng, Junchao |
|
|
28 |
6 |
p. 915-922 |
artikel |
11 |
Quality-Adjusted Life Expectancy by Socioeconomic Disadvantage and Remoteness Area: Population Norms for Australia
|
Rodda, Sheridan |
|
|
28 |
6 |
p. 923-929 |
artikel |
12 |
Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021
|
Hildebrandt, Meik |
|
|
28 |
6 |
p. 884-893 |
artikel |
13 |
Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations
|
Jin, Zixuan |
|
|
28 |
6 |
p. 959-974 |
artikel |
14 |
Table of Contents
|
|
|
|
28 |
6 |
p. i-v |
artikel |
15 |
The Health Inequality Impact of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer in the United States: A Distributional Cost-Effectiveness Analysis
|
Jansen, Jeroen P. |
|
|
28 |
6 |
p. 866-874 |
artikel |
16 |
The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level
|
Geuzinge, H. Amarens |
|
|
28 |
6 |
p. 930-935 |
artikel |
17 |
The Value of Positron Emission Tomography for Confirmation of Alzheimer’s Disease in the Era of Amyloid-Targeting Therapies
|
Veljanoska, Emilija |
|
|
28 |
6 |
p. 829-838 |
artikel |
18 |
Understanding the Economic Value of Interventions Addressing Perinatal Mental Health Problems: A Literature Review and Methodological Considerations
|
Bauer, Annette |
|
|
28 |
6 |
p. 821-828 |
artikel |
19 |
US Drug Pricing Patterns Before Loss of Exclusivity
|
Lin, Ching-Hsuan |
|
|
28 |
6 |
p. 907-914 |
artikel |
20 |
Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies
|
Jaksa, Ashley |
|
|
28 |
6 |
p. 898-906 |
artikel |
21 |
When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations
|
Metcalfe, Rebecca K. |
|
|
28 |
6 |
p. 839-843 |
artikel |
22 |
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?
|
Ramagopalan, Sreeram V. |
|
|
28 |
6 |
p. 976-977 |
artikel |